Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Receivables (2016 - 2025)

DarioHealth filings provide 13 years of Receivables readings, the most recent being $2.1 million for Q4 2025.

  • On a quarterly basis, Receivables fell 55.37% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 55.37% decrease, with the full-year FY2025 number at $2.1 million, down 55.37% from a year prior.
  • Receivables hit $2.1 million in Q4 2025 for DarioHealth, down from $2.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $7.9 million in Q1 2024 to a low of $468000.0 in Q1 2021.
  • Median Receivables over the past 5 years was $3.2 million (2023), compared with a mean of $3.7 million.
  • Biggest five-year swings in Receivables: skyrocketed 956.45% in 2021 and later crashed 62.03% in 2025.
  • DarioHealth's Receivables stood at $1.3 million in 2021, then surged by 389.77% to $6.4 million in 2022, then plummeted by 50.83% to $3.2 million in 2023, then soared by 52.27% to $4.8 million in 2024, then crashed by 55.37% to $2.1 million in 2025.
  • The last three reported values for Receivables were $2.1 million (Q4 2025), $2.4 million (Q3 2025), and $2.6 million (Q2 2025) per Business Quant data.